홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Hydrochloric Acid → 3-(4-chloro-2-(1-methyl-1H-pyrazol-5-yl)phenyl)-N-(1,2,4-thiadiazol-5-yl)-1H-indole-6-sulfonamide 3-(4-chloro-2-(1-methyl-1H-pyrazol-3-yl)phenyl)-N-(1,2,4-thiadiazol-5-yl)-1H-indole-6-sulfonamide

HRID 1524403
인쇄

반응식

HRID 1524403 반응식
[Cl:1][C:2]1[CH:7]=[CH:6][C:5]([C:8]2[C:16]3[C:11](=[CH:12][C:13]([S:17]([N:20](CC4C=CC(OC)=CC=4OC)[C:21]4[S:25][N:24]=[CH:23][N:22]=4)(=[O:19])=[O:18])=[CH:14][CH:15]=3)[NH:10][CH:9]=2)=[C:4]([C:37]2[N:41]([CH3:42])[N:40]=[CH:39][CH:38]=2)[CH:3]=1.Cl.[CH3:44]O>C(Cl)Cl>[Cl:1][C:2]1[CH:7]=[CH:6][C:5]([C:8]2[C:16]3[C:11](=[CH:12][C:13]([S:17]([NH:20][C:21]4[S:25][N:24]=[CH:23][N:22]=4)(=[O:18])=[O:19])=[CH:14][CH:15]=3)[NH:10][CH:9]=2)=[C:4]([C:37]2[CH:38]=[CH:39][N:40]([CH3:44])[N:41]=2)[CH:3]=1.[Cl:1][C:2]1[CH:7]=[CH:6][C:5]([C:8]2[C:16]3[C:11](=[CH:12][C:13]([S:17]([NH:20][C:21]4[S:25][N:24]=[CH:23][N:22]=4)(=[O:19])=[O:18])=[CH:14][CH:15]=3)[NH:10][CH:9]=2)=[C:4]([C:37]2[N:41]([CH3:42])[N:40]=[CH:39][CH:38]=2)[CH:3]=1
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

5

반응물 3

HCID 313Hydrochloric AcidHCID 887MethanolHCID 712592093-(4-chloro-2-(1-methyl-1H-pyrazol-5-yl)phenyl)-N-(2,4-dimethoxybenzyl)-N-(1,2,4-thiadiazol-5-yl)-1H-indole-6-sulfonamide2회

생성물 1

HCID 894076863-(4-chloro-2-(1-methyl-1H-pyrazol-5-yl)phenyl)-N-(1,2,4-thiadiazol-5-yl)-1H-indole-6-sulfonamide 3-(4-chloro-2-(1-methyl-1H-pyrazol-3-yl)phenyl)-N-(1,2,4-thiadiazol-5-yl)-1H-indole-6-sulfonamide수율 90%

시약·촉매·용매 1

HCID 6344Dichloromethane용매

실험 절차

A vial was charged with 3-(4-chloro-2-(1-methyl-1H-pyrazol-5-yl)phenyl)-N-(2,4-dimethoxybenzyl)-N-(1,2,4-thiadiazol-5-yl)-1H-indole-6-sulfonamide (Intermediate A) (28.44 mg, 0.046 mmol) in methanol (0.5 mL). Hydrogen chloride (4M in 1,4-dioxane) (114 μl, 0.458 mmol) was added, and the resulting mixture was stirred for 30 min. The mixture was diluted with DCM and concentrated in vacuo. The residue was suspended in MeOH, then filtered through Celite® (diatomaceous earth). The filtrate was concentrated, and the residue was dissolved in methanol and loaded onto a 500 mg SCX-2 ion exchange column. The column was eluted with methanol, then with a solution of 2N ammonia in methanol. The basic fractions were concentrated to give 3-(4-chloro-2-(1-methyl-1H-pyrazol-5-yl)phenyl)-N-(1,2,4-thiadiazol-5-yl)-1H-indole-6-sulfonamide 3-(4-chloro-2-(1-methyl-1H-pyrazol-3-yl)phenyl)-N-(1,2,4-thiadiazol-5-yl)-1H-indole-6-sulfonamide (19.36 mg, 0.041 mmol, 90% yield) as a light-yellow solid. 1H NMR (400 MHz, DMSO-d6) δ=11.57 (br. s., 1 H), 8.05 (s, 1 H), 7.85 (dd, J=0.5, 1.6 Hz, 1 H), 7.71-7.58 (m, 2 H), 7.54 (d, J=8.5 Hz, 1 H), 7.49 (d, J=2.2 Hz, 1 H), 7.43-7.33 (m, 2 H), 7.23-7.04 (m, 1 H), 6.93 (d, J=2.6 Hz, 1 H), 6.30 (d, J=1.9 Hz, 1 H), 3.19 (br. s., 1 H). m/z (ESI) 471.0 (M+H)+.

후처리

  1. concentrationconcentrated in vacuo
  2. filtrationfiltered through Celite® (diatomaceous earth)
  3. concentrationThe filtrate was concentrated
  4. dissolutionthe residue was dissolved in methanol
  5. washThe column was eluted with methanol
  6. concentrationThe basic fractions were concentrated

출처 및 근거

ORD 기록
ord-e663413906b146a29354bce62e0c6ac0
출처 데이터셋
uspto-grants-2015_07
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US09079902B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트